Vapotherm, Inc. – NYSE:VAPO
Vapotherm stock price today
$1.27
-0.85
-40.38%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 5 hours
Vapotherm stock price monthly change
+166.25%
month
Vapotherm stock price quarterly change
+33.13%
quarter
Vapotherm stock price yearly change
+273.23%
year
Vapotherm key metrics
Market Cap | 13.55M |
Enterprise value | 98.28M |
P/E | -0.14 |
EV/Sales | 1.47 |
EV/EBITDA | -1.02 |
Price/Sales | 0.25 |
Price/Book | -0.60 |
PEG ratio | N/A |
EPS | -8.71 |
Revenue | 70.07M |
EBITDA | -27.11M |
Income | -54.93M |
Revenue Q/Q | 7.91% |
Revenue Y/Y | 11.38% |
Profit margin | -169.55% |
Oper. margin | -150.28% |
Gross margin | 25.81% |
EBIT margin | -150.28% |
EBITDA margin | -38.7% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeVapotherm stock price history
Vapotherm stock forecast
Vapotherm financial statements
| Jun 2023 | 16.03M | -14.78M | -92.21% |
|---|---|---|---|
| Sep 2023 | 15.16M | -15.13M | -99.76% |
| Dec 2023 | 19.73M | -10.18M | -51.61% |
| Mar 2024 | 19.13M | -14.83M | -77.54% |
| 2025 | 101.92M | -25.99M | -25.5% |
|---|
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 90084000 | 124.54M | 138.25% |
|---|---|---|---|
| Sep 2023 | 80604000 | 128.1M | 158.93% |
| Dec 2023 | 77617000 | 132.95M | 171.29% |
| Mar 2024 | 71907000 | 140.38M | 195.24% |
| Jun 2023 | -7.35M | -404K | 80K |
|---|---|---|---|
| Sep 2023 | -2.95M | -554K | 0 |
| Dec 2023 | -3.92M | -1.03M | 15K |
| Mar 2024 | -6.55M | -1.41M | 1.67M |
Vapotherm alternative data
| Aug 2023 | 261 |
|---|---|
| Sep 2023 | 261 |
| Oct 2023 | 261 |
| Nov 2023 | 261 |
| Dec 2023 | 261 |
| Jan 2024 | 261 |
| Feb 2024 | 261 |
| Mar 2024 | 182 |
| Apr 2024 | 182 |
| May 2024 | 182 |
| Jun 2024 | 182 |
| Jul 2024 | 182 |
Vapotherm other data
18.78%
-17.85%
of VAPO is owned by hedge funds
28
-25
5.02M
-4.75M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2022 | 1116950 | 1065016 |
| Dec 2022 | 199652 | 0 |
| Feb 2023 | 2752376 | 0 |
| Aug 2023 | 387750 | 0 |
| Sep 2023 | 100000 | 0 |
| Patent |
|---|
Grant Utility: Quiet nasal cannula Filling date: 12 Apr 2019 Issue date: 13 Sep 2022 |
Grant Filling date: 5 Mar 2019 Issue date: 13 Sep 2022 |
Application Filling date: 6 May 2022 Issue date: 25 Aug 2022 |
Application Filling date: 23 Dec 2021 Issue date: 21 Jul 2022 |
Grant Utility: Nasal cannula for continuous and simultaneous delivery of aerosolized medicament and high flow therapy Filling date: 30 Jun 2016 Issue date: 21 Jun 2022 |
Grant Filling date: 13 Oct 2017 Issue date: 7 Jun 2022 |
Grant Utility: Cannula device for high flow therapy Filling date: 29 Jun 2017 Issue date: 5 Apr 2022 |
Application Filling date: 24 Sep 2021 Issue date: 31 Mar 2022 |
Grant Utility: Vapor transfer cartridge Filling date: 20 Oct 2016 Issue date: 15 Mar 2022 |
Application Filling date: 29 Jun 2021 Issue date: 24 Feb 2022 |
| Quarter | Transcript |
|---|---|
| Q3 2023 8 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 6 May 2023 | Q1 2023 Earnings Call Transcript |
| Q4 2022 23 Feb 2023 | Q4 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Joseph F. Army CPA, CPA (1964) Chief Executive Officer, Pres & Director | $1,300,000 |
| Mr. Gregoire Ramade (1970) Senior Vice President & Chief Commercial Officer | $851,270 |
| Mr. John Landry (1973) Senior Vice President, Chief Financial Officer & Treasurer | $700,730 |
-
What's the price of Vapotherm stock today?
One share of Vapotherm stock can currently be purchased for approximately $1.27.
-
When is Vapotherm's next earnings date?
Unfortunately, Vapotherm's (VAPO) next earnings date is currently unknown.
-
Does Vapotherm pay dividends?
No, Vapotherm does not pay dividends.
-
How much money does Vapotherm make?
Vapotherm has a market capitalization of 13.55M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.8% to 68.67M US dollars.
-
What is Vapotherm's stock symbol?
Vapotherm, Inc. is traded on the NYSE under the ticker symbol "VAPO".
-
What is Vapotherm's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Vapotherm?
Shares of Vapotherm can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Vapotherm's key executives?
Vapotherm's management team includes the following people:
- Mr. Joseph F. Army CPA, CPA Chief Executive Officer, Pres & Director(age: 61, pay: $1,300,000)
- Mr. Gregoire Ramade Senior Vice President & Chief Commercial Officer(age: 55, pay: $851,270)
- Mr. John Landry Senior Vice President, Chief Financial Officer & Treasurer(age: 52, pay: $700,730)
-
How many employees does Vapotherm have?
As Jul 2024, Vapotherm employs 182 workers.
-
When Vapotherm went public?
Vapotherm, Inc. is publicly traded company for more then 6 years since IPO on 14 Nov 2018.
-
What is Vapotherm's official website?
The official website for Vapotherm is vapotherm.com.
-
Where are Vapotherm's headquarters?
Vapotherm is headquartered at 100 Domain Drive, Exeter, NH.
-
How can i contact Vapotherm?
Vapotherm's mailing address is 100 Domain Drive, Exeter, NH and company can be reached via phone at +60 36580011.
Vapotherm company profile:
Vapotherm, Inc.
vapotherm.comExchange:
NYSE
Full time employees:
182
Industry:
Medical - Devices
Sector:
Healthcare
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
100 Domain Drive
Exeter, NH 03833
Exeter, NH 03833
CIK: 0001253176
ISIN: IE0003LFZ4U7
CUSIP: 922107107
